Irritable Bowel Syndrome: all 1,084 studies

Page 7 of 11. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Understanding Abdominal Pain in IBD and IBSStatus unknownNCT04020835
• Identification of Gluten Sensitivity in Irritable Bowel SyndromeCompletedNCT04017585Not applicable
• Fecal Microbiota Transplantation for Health Improvement (TFM3)Status unknownNCT04011943Not applicable
• The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia SubjectsCompletedNCT04008901Phase 3
• A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS SymptomsCompletedNCT03997708Not applicable
• The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel SyndromeCompletedNCT03986476Not applicable
• qQ-lab Daily-IBS for Irritable Bowel SyndromeCompletedNCT03964103Not applicable
• Implementing a Low FODMAP Diet in Irritable Bowel Syndrome PatientsCompletedNCT03948854Not applicable
• Botanical Tincture for Symptoms of Irritable Bowel SyndromeWithdrawnNCT03923322Phase 2
• Effect of Serotonergic Stimulation on the Gut-brain AxisCompletedNCT03920410Not applicable
• Long - Term Low Anterior Resection SyndromeCompletedNCT03920202
• Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel SyndromeCompletedNCT03899779Not applicable
• Cerebral Cortical Influences on Autonomic FunctionCompletedNCT03869372Not applicable
• The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy VolunteersCompletedNCT03869359Not applicable
• Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a QuestionnaireCompletedNCT03824821
• Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?CompletedNCT03823742Not applicable
• Effects of Faecal Microbiota Transplantation in Patients With IBSCompletedNCT03822299Not applicable
• Panaceo "MED" for IBS (Irritable Bowel Syndrome)CompletedNCT03817645Not applicable
• A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS PatientsCompletedNCT03815617Phase 3
• Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring ColonoscopyCompletedNCT03806959Not applicable
• Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)CompletedNCT03803319Not applicable
• Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel SyndromeCompletedNCT03801057Not applicable
• The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control GroupStatus unknownNCT03778918
• Carbohydrate Reduction and Impact on Gastrointestinal SystemCompletedNCT03729622Not applicable
• Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant DiarrheaCompletedNCT03729271Phase 4
• Microbiota Profiling in IBSCompletedNCT03720314
• Health Education Delivery Methods for a Low Fermentable Carbohydrate Diet in Patients With Functional Bowel DisordersCompletedNCT03694223Not applicable
• Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac PatientsCompletedNCT03678935Not applicable
• Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBSCompletedNCT03675100Not applicable
• Postoperative Bowel Function After SPS by Different Reconstruction MethodsCompletedNCT03669237Not applicable
• Identification of IBS Metabotypes Based on Physiological Responses to FoodCompletedNCT03653689Not applicable
• Low FODMAPs Diet in Gastrointestinal DisordersCompletedNCT03644602Not applicable
• Reduced Content of Gluten Diet on Patients With Irritable Bowel Syndrome (Pro.Ali.Fun.)CompletedNCT03638544Not applicable
• The Predictive Value of Alarm Symptoms in Patients With Irritable Bowel Syndrome Based on Rome IVStatus unknownNCT03620994
• One Year Home Monitoring and Treatment of IBS PatientsStatus unknownNCT03586622Not applicable
• Effect of Curcumin on Gut Microbiota in IBSCompletedNCT03568513Not applicable
• FMT in the Treatment of IBSCompletedNCT03561519Not applicable
• Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel SyndromeCompletedNCT03557788Phase 4
• TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron TrialCompletedNCT03555188Phase 3
• Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS PatientsCompletedNCT03550742Not applicable
• Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian FederationCompletedNCT03549143
• Mucosal Innate Immune Activation in Chronic Intestinal DisordersWithdrawnNCT03529318
• Gluten Free Diet in IBS Patients Stratified According to Their Antigliadin StatusCompletedNCT03492333Not applicable
• Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)CompletedNCT03471728
• Patient Education for Patients With Irritable Bowel Syndrome (IBS)CompletedNCT03466281Not applicable
• Endpoint Determination Study ProtocolCompletedNCT03459482Not applicable
• Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel SyndromeStatus unknownNCT03457324Phase 2/3
• SMART Program in Irritable Bowel Syndrome (IBS)CompletedNCT03454386Not applicable
• L. Casei DG® in Patients With Irritable Bowel Syndrome.CompletedNCT03449628Not applicable
• Transcutaneous Vagus Nerve Stimulation in Private Healthcare CenterCompletedNCT03440255Not applicable
• Individual vs. Group Hypnotherapy in Patients With Irritable Bowel SyndromeActive, not recruitingNCT03432078Not applicable
• Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal VariantCompletedNCT03423069Not applicable
• Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS)CompletedNCT03379064Not applicable
• Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel SyndromeActive, not recruitingNCT03370614
• Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy SubjectsCompletedNCT03366389
• Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome PatientsCompletedNCT03359499Phase 2/3
• Cognitive and Psychiatric Effects of Linaclotide on Patients With ConstipationWithdrawnNCT03342287
• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenCompletedNCT03339128Phase 2
• Assessment of Responsiveness to Treatment by Experience Sampling MethodTerminatedNCT03336034
• Fecal Transplantation in Patients With IBSCompletedNCT03333291Not applicable
• Precision Pain Self-Management in Young Adults With Irritable Bowel SyndromeCompletedNCT03332537Not applicable
• Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood DisasterCompletedNCT03318614Phase 2/3
• The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBSCompletedNCT03306381Not applicable
• Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in ChinaCompletedNCT03304041Not applicable
• Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)CompletedNCT03300804Phase 2
• Mediterranean Diet and the Gut MicrobiomeCompletedNCT03269032Not applicable
• Epidemiology and Pathophysiology of Post-Infectious Functional GI DisordersCompletedNCT03266068
• Fibre and Gas in Irritable Bowel SyndromeCompletedNCT03265002Not applicable
• ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.CompletedNCT03252743Not applicable
• Multi-strain Probiotic in the Management of IBS-DCompletedNCT03251625Phase 4
• FODMAP Reintroduction in Irritable Bowel SyndromeCompletedNCT03245645Not applicable
• Reclassifying Constipation Using Imaging and ManometryStatus unknownNCT03226145Not applicable
• The Effect of Citrus Extract on Gastrointestinal HealthCompletedNCT03225261Phase 2
• Evaluation of Bowel Sensitivity Threshold in IBS Patients Versus in Healthy Controls Using the Novel Rapid Barostat BagStatus unknownNCT03224494Not applicable
• Effect of FODMAPs on Mucosal Inflammation in IBS PatientsStatus unknownNCT03221790Not applicable
• Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the ColonTerminatedNCT03220711Not applicable
• Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical HomeCompletedNCT03186872Not applicable
• The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related FactorsCompletedNCT03178877
• Inuline Supplement in Patients With Irritable Bowel SyndromeStatus unknownNCT03174561Not applicable
• Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C PhenotypeCompletedNCT03150212Not applicable
• Vitamin D Supplementation in IBSTerminatedNCT03148288Not applicable
• Fecal Calprotectin Collection ProtocolCompletedNCT03143517
• Mobile Self-Management of Irritable Bowel Syndrome for AdolescentsCompletedNCT03138980Not applicable
• Traditional Chinese Medicine for Treatment of Irritable Bowel SyndromeStatus unknownNCT03135821Phase 2/3
• The IMAGINE-SPOR CIHR Chronic Disease NetworkStatus unknownNCT03131414
• FMT for Patients With IBS With Fecal and Mucosal Microbiota AssessmentCompletedNCT03125564Not applicable
• Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-DCompletedNCT03099785Phase 2
• Brief Behavioral Treatment for Sleep Problems in IBS StudyCompletedNCT03087799Not applicable
• ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human StoolCompletedNCT03082287
• The Multi-disciplinary Treatment of Functional Gut Disorders StudyCompletedNCT03078634Not applicable
• The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS)Status unknownNCT03074227Not applicable
• Correlation Between Central Sensitization Inventory and Posturographic DataCompletedNCT03058003
• Diet Reintroduction Study in Irritable Bowel SyndromeCompletedNCT03052439Not applicable
• OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut MicrobiomeCompletedNCT03051204
• Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal HealthCompletedNCT03046667Not applicable
• Comparing Two Types of Diets on Psychological and Gastrointestinal SymptomsCompletedNCT03035799Not applicable
• Gynaecological Disorders in Not-celiac Wheat SensitivityCompletedNCT03027492Not applicable
• Duodenal and Rectal Histology in Non-celiac Wheat Sensitivity and Irritable Bowel Syndrome PatientsCompletedNCT03022994
• Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional CounselingCompletedNCT03019861Not applicable
• Effect of UGIR in Adults With Compromised Gut Function and MalabsorptionCompletedNCT03011593Not applicable

← Irritable Bowel Syndrome overview